Hopital Erasme
Brussels, 1070, Belgium
NCT Number: NCT04480216
A novel magnetic device, called MAgnetic Gastrointestinal Universal Septotome (MAGUS) was designed to improve the Treatment of diverticulum of the esophagus, Pseudo-diverticulum of the upper GI tract, Candy cane syndrome This study aims to evaluating the safety of the feasability of this new device.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Brussels, 1070, Belgium
In this study, the investigators aim at treating different pathological conditions, resulting in the appearance of a septum separating a healthy pathway and a pathological pouch. Food then stagnate in this pouch and results in different symptoms including dysphagia, pain and/or regurgitation or postprandial dysrhythmia.
Esophageal diverticula consists in the apparition of a pouch (diverticulum) alongside the esophagus. Some post-surgical conditions can result in the appearance of pseudo-diverticulum or afferent limb that transforms into a large pouch. One example is the candy cane syndrome, being an afferent loop syndrome post gastrectomy or post Roux-en-Y Gastric Bypass, were the afferent limb becomes a structure similar to a large diverticulum.
All those pathological conditions could be solved by the marsupialization of those (pseudo-)diverticulum. For several years, Zenker's diverticula (pharyngo-esophageal diverticulum) have been treated endoscopically using this technique, providing good clinical results. However, it is difficult to go further than the pharynx with this technique, since it needs specific semi-rigid tools and a stable cutting position. Hence, for further septa of the GI tract, the classic treatment is thoracoscopy and thoracotomy or laparoscopy and laparotomy, depending on the site. Those highly invasive procedures have a significant mortality and morbidity rate respectively of more than 5% and 20% and are liked to different complications including abdominal pain, port site wound infections, intraabdominal collection or anastomosis ulcer.
The MAGUS device consists of a flexible catheter preloaded with a magnetic device, made of two magnets linked by a wire. Each magnet is attached to the catheter and can be dropped separately from this catheter. The magnetic device aims to create an anastomosis by means of compression, using magnetic force and a retractable wire pulling system. For a given septum, the magnets are placed on either sides of the bottom of it. The retractable wire goes then from one another, passing on top of the septum. Both creates compression necrosis. This process induces eventually a cutting of the septum.
Once the cutting is performed, the magnets migrate and are expelled through natural ways.
The MAGUS device is an endoscopic procedure. Above standard of care monitoring, safety assessment of the procedure and device performance decreases the risk and unforeseen events.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An upper endoscopy will be performed with the use of fluoroscopy. The MAGUS will be placed under fluoroscopy. The good positioning and the absence of any complications will be confirmed by gastroscopy.
An injection of contrast agent will be done to be sure of the correct positioning and that no complications was happened.
The patient will be kept overnight, with liquid food for 2 and mashed food up to 7 days post procedure
Time frame: Day 0
ability to deploy the MAGUS in satisfactory position across the septum (YES/NO)
Time frame: During 28 Days post-placement
natural or endoscopic
Time frame: During 30 days post-placement
SAE during device placement
Time frame: During 3 month post placement
Time frame: Before treatment - Day 1 - Day 14 - Day 28 - Month 3
scored by a visual analog scale from 0 to 10 (0=no pain)
Time frame: During 3 months post-placement
Time frame: Before treatment - Day 1 - Day 14 - Day 28 - Month 3
Time frame: Day 14 - Day 28 - Month 3
scored by a visual analogue scale from 0 to 10 (10= fully satisfied)
Time frame: Month 3
Time frame: Month 3
Time frame: Before treatment - Month 3
Erasme University Hospital
Other
MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study
Acronym: MAGUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02525705
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Bordeaux, France
View Trial DetailsNCT01794793
Acromegaly, Bone Diseases
La Jolla, California, United States
View Trial DetailsNCT05057819
Digestive System Diseases, Dumping Syndrome
Bern, Canton of Bern, Switzerland
View Trial DetailsNCT01923649
Digestive System Diseases, Dumping Syndrome
Brugges, Belgium
View Trial Details